pharma · Breast Cancer · Lumbosacral Radicular Pain · SMNR
Semnur Pharmaceuticals
Semnur Pharmaceuticals is a pharma organization headquartered in Palo Alto, USA. It trades on NYSE under ticker SMNR. Primary therapeutic focus areas include Breast Cancer, Lumbosacral Radicular Pain. NovaPharmaNews link
Palo Alto, USA HQ
2013 Founded
9 Employees
Public company Type
SMNR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Palo Alto, USA
- Founded
- 2013
- Employees
- 9
- Programs
- 2
- Drugs
- 2
- Patents
- 8
SP-102
Phase 3 · small molecule · Lumbosacral Radicular Pain
SP-102 for Lumbosacral Radicular Pain is a Phase 3 program (small_molecule) at Semnur Pharmaceuticals with 3 ClinicalTrials.gov record(s).
Internal code SP-102-03
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Semnur Pharmaceuticals
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Lumbosacral Radicular Pain
- Status
- active
- Trials
- 3